(Q68161612)
Statements
A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia (English)
Laux G
Klieser E
Schröder HG
Dittmann V
Unterweger B
Schubert H
König P
Schöny HW
Bunse J
Beckmann H
1 January 1990